
Anticipation and applause filled the air on Friday, March 20, as Feinberg students gathered with family, friends and faculty to learn where they will begin the next phase of their medical training during Match Day 2026.

A new study has shed light on why patients with certain rare immune disorders develop severe, food‑triggered allergic reactions while others with similar diagnoses do not.

A global clinical trial has found that recombinant factor VIIa, a drug designed to rapidly slow bleeding in the brain after a hemorrhagic stroke, does not improve long‑term recovery for patients, according to a study published in The Lancet

Screening all young people for a genetic form of dangerously high cholesterol could prevent heart attacks and strokes later in life, but would not be cost-effective under the current healthcare system, according to a new modelling study published in JAMA.

A Northwestern Medicine study has shed light on one of the most intricate construction projects in biology: how cells build and coordinate the internal scaffolding needed to create a healthy egg, according to a recent study published in the Journal of Cell Biology.

A multicenter clinical trial published in JAMA has found that a long-used endoscopic procedure does not prevent recurrent pancreatitis in adults with an anatomic anomaly, challenging decades of conventional wisdom.

Northwestern Medicine scientists have zeroed in on a cellular gatekeeper that may hold promise for treating abnormal protein accumulation in neurodegenerative diseases, according to a study published in Nature Communications.

A Northwestern Medicine-led study published in The Journal of Clinical Investigation has uncovered why older individuals with specific genetic mutations face a heightened risk of developing serious blood cancers.

A common diabetes medication does not help people with peripheral artery disease (PAD) walk farther, according to results from a major U.S. clinical trial published in JAMA.

A new experimental therapy has shown encouraging results in treating a rare and progressive lysosomal storage disorder, according to findings from a multi-year clinical trial published in the New England Journal of Medicine.